π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
CD70 is a promising target for immunotherapy because it is overexpressed in...
Status
Recruiting
Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2024-12-01
Trial ID
NCT06696846
Treatments Being Tested
To study the safety and efficacy of cord blood-derived CAR-NK cells targeti...
Status
Unknown
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2022-12-15
Trial ID
NCT05667155
Treatments Being Tested
To find the highest tolerable dose of dualCAR-NK19/70 (a type of cell thera...
Status
Recruiting
Location
Shanghai Tongji Hospital, Tongji University School of Medicine
Start Date
2023-01-18
Trial ID
NCT05842707
Treatments Being Tested
Testing an investigational cancer therapy called TGFBR-2 KO CD70 CAR NK cel...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2025-09-25
Trial ID
NCT07072234
Treatments Being Tested
Phase 1/2 study evaluates the safety, feasibility, and preliminary antitumo...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-02-02
Trial ID
NCT07551349
Treatments Being Tested
This clinical research study is to learn if CD70.CAR NK cell therapy can he...
Status
Not Yet Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2026-12-28
Trial ID
NCT07164469
Treatments Being Tested